From Oligos to Genes to Pathways to Genomes-DNA construction for Synthetic Biology


: Breakout Sessions

: Exciting Science 2010

: Monday May 3, 2010

: 2:00 PM - 3:30 PM

: McCormick Place, Chicago

: S405B

: Synthetic biology, the largest growing segment in biotechnology, is already enabling bio-based manufacturing of drugs, chemicals, materials and biofuels. An increasing number of companies in this field rely heavily on DNA construction technologies and focus on developing multi-gene pathways and de novo genomes. This session brings together people from industry and academia to discuss DNA construction technologies (oligo and gene synthesis, and pathway and genome assembly). The discussion will cover researchers’ needs for DNA construction technologies, current bottlenecks, future technical and commercial development perspectives, and key challenges inherent to large-scale DNA construction.

Program: Advanced


:
1. Gain an overview of emerging DNA construction technologies.

2. Learn the core technical challenge of DNA construction at each length scale.

3. Be able to identify potential commercial opportunities in DNA construction.


Jason Kelly, PhD - Chair
CEO Ginkgo BioWorks
Ginkgo BioWorks

Harris Wang, PhD
Researcher
Harvard Medical School

Chris French, PhD
Lecturer
The University of Edinburgh

Shawn Allen
VP of Chemistry and Development
Integrated DNA Technologies

Todd Peterson
Vice President Cloning and Protein Expression R & D
Life Technologies

Jason Kelly, PhD
CEO Ginkgo BioWorks
Ginkgo BioWorks